| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/16/2013 | EP2648761A1 Cancer gene therapy using nucleic acids encoding us28 and g-protein |
| 10/16/2013 | EP2648760A2 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity |
| 10/16/2013 | EP2648754A2 Methods of inhibiting metastasis from cancer |
| 10/16/2013 | EP2648747A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib |
| 10/16/2013 | EP2648738A2 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents |
| 10/16/2013 | EP2648734A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer |
| 10/16/2013 | EP2648729A1 Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer |
| 10/16/2013 | EP2648727A2 Compositions and methods for mobilizing stem cells |
| 10/16/2013 | EP2648721A1 Combinations of aromatase inhibitors and antioxidants |
| 10/16/2013 | EP2648719A1 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1 |
| 10/16/2013 | EP2648710A1 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| 10/16/2013 | EP2648709A1 Disulfiram formulation and uses thereof |
| 10/16/2013 | EP2648708A2 Combination for breast cancer therapy with hsp90 inhibitory compounds |
| 10/16/2013 | EP2648706A2 Compositions and methods relating to proliferative diseases |
| 10/16/2013 | EP2648516A1 Substituted pyridinone-pyridinyl compounds |
| 10/16/2013 | EP2648509A2 Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof |
| 10/16/2013 | EP2399937A9 Anti-human alpha9 integrin antibody and use thereof |
| 10/16/2013 | CN103354833A Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
| 10/16/2013 | CN103352051A PcDNA3.1(+)-Fbw7 (F-box and WD repeat domain-containing 7) recombinant plasmid as well as construction method and application of PcDNA3.1(+)-Fbw7 recombinant plasmid |
| 10/16/2013 | CN103352042A cDNA encoding recombinant Newcastle disease virus, virus rescued by cDNA, and application of cDNA in malignant tumor treatment |
| 10/16/2013 | CN103352036A SiRNA molecule targeting tumor related genes and application thereof |
| 10/16/2013 | CN103351438A Anti-cmet antibody |
| 10/16/2013 | CN103351425A Disheveled pdz modulators |
| 10/16/2013 | CN103351423A Peptide vaccines for cancers expressing tumor-associated antigens |
| 10/16/2013 | CN103351415A Method for preparing salidrosides with a series of purities from glossy privet fruit |
| 10/16/2013 | CN103351397A Gambogic acid derivative, preparation method and uses thereof |
| 10/16/2013 | CN103351395A Esterified podophyllum derivative with antineoplastic activity and preparation method and application thereof |
| 10/16/2013 | CN103351394A Acidamide substitution podophyllum derivative with antineoplastic activity and preparation method and application thereof |
| 10/16/2013 | CN103351383A 5-fluorouracil nitroxyl-free-radical anti-tumor drug |
| 10/16/2013 | CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof |
| 10/16/2013 | CN103351333A Aryl pyridine derivative compound and preparation method thereof |
| 10/16/2013 | CN103351308A Positively charged water-soluble 4-acetamidophenol having rapid skin penetration speed, and related compound prodrug thereof |
| 10/16/2013 | CN103349783A Nano photosensitive drug taking amphiphilic polysaccharide-folic acid conjugate as carrier and preparation method thereof |
| 10/16/2013 | CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 10/16/2013 | CN103349764A Medicine for treating breast cancer and preparation method thereof |
| 10/16/2013 | CN103349759A Traditional Chinese medicine composition for treating ovarian cyst |
| 10/16/2013 | CN103349732A Dendrobium officinale kimura et migo-panax quinquefolius buccal tablets for diabetes patients, and preparation method thereof |
| 10/16/2013 | CN103349713A Natural pharmaceutical extractive, as well as preparation method and use thereof |
| 10/16/2013 | CN103349703A Natural pharmaceutical composition, as well as preparation method and use thereof |
| 10/16/2013 | CN103349702A Natural medicine composition and preparation method and purposes thereof |
| 10/16/2013 | CN103349698A Natural pharmaceutical extractive, and preparation method thereof |
| 10/16/2013 | CN103349697A Natural medicine extractive and preparation method and uses thereof |
| 10/16/2013 | CN103349687A Compound Indian buead particle and preparation method thereof |
| 10/16/2013 | CN103349681A Natural medicine composition |
| 10/16/2013 | CN103349680A Natural pharmaceutical extractive |
| 10/16/2013 | CN103349672A Preparation method of traditional Chinese medicinal preparation Omphalia powder for auxiliary treatment of cancers |
| 10/16/2013 | CN103349668A Application of Polyflavanostilbene A in preparing drug for treating endometrial cancer |
| 10/16/2013 | CN103349664A Steroidal c- 17 benzoazoles |
| 10/16/2013 | CN103349661A Preparation method and application of formononetin-5-FU mixture |
| 10/16/2013 | CN103349660A New application of 8-methoxy-dihydrochelerythrine in preparation of STAT3 (signal transducer and activator of transcription3) signal path inhibitor |
| 10/16/2013 | CN103349655A Tamoxifen citrate enteric capsules |
| 10/16/2013 | CN103349652A High drug load tablet containing tetrahydronaphthalene amide compound or pharmaceutically acceptable salt thereof |
| 10/16/2013 | CN103349650A Tamoxifen citrate sustained-release tablets |
| 10/16/2013 | CN103349649A Tamoxifen citrate dispersible tablets |
| 10/16/2013 | CN103349648A Tamoxifen citrate enteric-coated tablets |
| 10/16/2013 | CN103349647A Tamoxifen citrate sustained-release granules |
| 10/16/2013 | CN102872149B Application of Houttuynoid B in medicament for treating cecum cancer |
| 10/16/2013 | CN102755512B Traditional Chinese medicine extract capable of improving CIK cell proliferation rate as well as preparation method |
| 10/16/2013 | CN102698057B Medicine for treating bladder tumor |
| 10/16/2013 | CN102698042B Traditional Chinese medicine for treating liver cancer |
| 10/16/2013 | CN102676396B Paecilomyces tenuipes strain and application thereof |
| 10/16/2013 | CN102675416B Beta-carboline derivatives, and preparation method and application thereof |
| 10/16/2013 | CN102652735B Porous silica nano particle loaded with medicaments with slight solubility and preparation method and application of particle |
| 10/16/2013 | CN102617584B Irinotecan hydrochloride compound and medicinal composition thereof |
| 10/16/2013 | CN102614365B Traditional Chinese medical composition for treatment of breast tumor |
| 10/16/2013 | CN102614308B Method for extracting bioactivator in hot chili residue through subcritical water |
| 10/16/2013 | CN102552638B Anticancer drug, as well as preparation method and application of same |
| 10/16/2013 | CN102552245B Composition containing epigallocatechin gallate and taxol for suppressing tumor cell proliferation |
| 10/16/2013 | CN102552154B Albumin nanoparticle preparation for anthracycline antitumor antibiotic oleic acid compound |
| 10/16/2013 | CN102526431B Traditional Chinese medicine preparation for treating gastric cancer and preparation method |
| 10/16/2013 | CN102512516B Medicinal moxa roll for treating mammary gland tumors and preparation method thereof |
| 10/16/2013 | CN102504026B Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof |
| 10/16/2013 | CN102491935B Nitrobenzaldehyde indole schiff base, preparation method and application thereof |
| 10/16/2013 | CN102421778B Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 10/16/2013 | CN102372741B Zoledronic acid crystal and lyophilized powder injection thereof |
| 10/16/2013 | CN102344371B Temperature-sensing amphiphilic polyether dendrons and their preparation method and use |
| 10/16/2013 | CN102335165B Application of flavonoids compounds in breast cancer resistance |
| 10/16/2013 | CN102277398B Process for preparing modified pectin with high bioavailability and antitumor application of modified pectin |
| 10/16/2013 | CN102276597B 14-membered macrolide epothilone compounds and application thereof |
| 10/16/2013 | CN102272134B Modulators of toll-like receptors |
| 10/16/2013 | CN102250022B Substituted quinoxalinamine compounds, and preparation method and application thereof |
| 10/16/2013 | CN102241969B Small-molecule fluorescent probes for quinazoline alpha1-adrenergic receptors and application of small-molecule fluorescent probes |
| 10/16/2013 | CN102088979B Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin-4-yl] oxy}quinazoline |
| 10/16/2013 | CN102083799B Benzimidazole derivatives used as FXR agonists |
| 10/16/2013 | CN102056926B Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 10/16/2013 | CN102051362B Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof |
| 10/16/2013 | CN101951932B Use of extract of piper betel leaves for the treatment of human malignancies sensitive to oxidative stress |
| 10/16/2013 | CN101885778B HPV (Human Papilloma Virus) 16 type L2N120E7E6 fusion protein, gene, preparation method and application |
| 10/16/2013 | CN101810862B Tanshinone IIA oral administration polymer micelle composition |
| 10/16/2013 | CN101784543B Indole and indazole compounds as an inhibitor of cellular necrosis |
| 10/16/2013 | CN101605905B Method for glycosylation of flavonoid |
| 10/16/2013 | CN101600706B Akt活性抑制剂 Akt activity inhibitor |
| 10/16/2013 | CN101589026B Method of treatment of glioma brain tumour |
| 10/16/2013 | CN101535344B Novel antiproliferation antibodies |
| 10/16/2013 | CN101245101B Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146 |
| 10/15/2013 | US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 10/15/2013 | US8557996 Heteroaryl-substituted alkyne compounds and method of use |
| 10/15/2013 | US8557859 Immunomodulatory compositions |
| 10/15/2013 | US8557857 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 10/15/2013 | US8557845 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |